COVID Drug May Also Ease Symptoms of Long COVID
An antiviral drug approved for high-risk COVID patients may also benefit those with long COVID, according to the findings of a small case series that need to be confirmed with future rigorous studies.
University of California San Francisco
Give to UCSF
UCSF Names Kathy Giacomini Dean of Pharmacy School
Kathy Giacomini, PhD, who trained as a pharmacist and went on to become one of the foremost experts on pharmacogenomics with a focus on drug transporters, has been appointed dean of the UCSF School of Pharmacy.
How the Discovery of an Alzheimer’s Tipping Point Could Improve Drug Trials
In a study, UCSF neurologist William Seeley, MD, and colleagues identified two key moments in the natural history of Alzheimer’s, pointing to a window of opportunity for treatment with amyloid-lowering drugs.
Seniors with Memory Issues Take Multiple Medications, but Most Are Willing to Cut Down
55% of seniors with dementia take more than six medications even though most have good health. However, a UCSF study showed that 87% are willing to cut down if their doctors agree.
Treating Tough Tumors by Exploiting Their Iron ‘Addiction’
UCSF researchers successfully leveraged an FDA-approved drug to halt growth of tumors driven by mutations in the RAS gene, which are famously difficult to treat and account for about one in four cancer deaths.
Solving the Mystery of a Stubborn – and Common – Cancer Gene
Mark Moasser, MD, has sorted out why HER2, the protein driving 1 in 5 breast cancers, is so hard to drug. He explains how the findings correct a naive way of envisioning how HER2 is shaped and how it works.
Drug Offers New Hope to Select Patients with ALS, UCSF-CPMC Study Shows
A UCSF-led study found a new drug for ALS that shows to slow or temporarily stall the progression of ALS in a select group of patients, with three times as many patients' disease slowing compared to those who received a placebo.
Race-Based Prescribing for Black People with High Blood Pressure Shows No Benefit
For years, physicians have been taught to prescribe different drugs to Black people with high blood pressure. A recent UCSF study calls that into question.
Human Proteins Behind COVID-19 Infection Revealed by Innovative CRISPR Technology
In the quest for new treatments for COVID-19, a team led by UCSF researchers identified a new potential drug target that may prevent infection of human cells by SARS-CoV-2.
As Omicron Surges, UCSF Experts Answer Questions About the COVID-19 Variant
There is some information that is known about the variant and other information that sti
Are Generic Drugs on a Par with Pricier Brands?
Americans save billions of dollars using lower-cost generics instead of brand-name drugs. Are they as effective?
COVID Patients on SSRI Antidepressants Are Less Likely to Die, UCSF-Stanford Study Finds
A UCSF and Stanford study of electronic health records linked SSRIs, the most widely prescribed antidepressants, to survival for COVID-19 patients.
